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ABSTRACT
Sperm capacitation is required for fertilization. At the molecular
level, this process is associated with fast activation of protein kinase
A. Downstream of this event, capacitating conditions lead to an
increase in tyrosine phosphorylation. The identity of the tyrosine
kinase(s) mediating this process has not been conclusively
demonstrated. Recent experiments using stallion and human
sperm have suggested a role for PYK2 based on the use of small
molecule inhibitors directed against this kinase. However, crucially,
loss-of-function experiments have not been reported. Here, we used
both pharmacological inhibitors and genetically modified mice
models to investigate the identity of the tyrosine kinase(s)
mediating the increase in tyrosine phosphorylation in mouse
sperm. Similar to stallion and human, PF431396 blocks the
capacitation-associated increase in tyrosine phosphorylation. Yet,
sperm from Pyk2−/− mice displayed a normal increase in tyrosine
phosphorylation, implying that PYK2 is not responsible for this
phosphorylation process. Here, we show that PF431396 can also
inhibit FER, a tyrosine kinaseknown to bepresent in sperm. Sperm from
mice targetedwith akinase-inactivatingmutation inFer failed to undergo
capacitation-associated increases in tyrosine phosphorylation.
Although these mice are fertile, their sperm displayed a reduced ability
to fertilize metaphase II-arrested eggs in vitro.
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INTRODUCTION
Mammalian sperm acquire fertilization competence in the female
tract in a process known as capacitation. Capacitation is associated
with changes in motility pattern (e.g. hyperactivation) and prepares
sperm to undergo acrosomal exocytosis. At the molecular level, one
of the first events is a fast HCO3
−-dependent stimulation of cAMP
synthesis by the atypical soluble adenylyl cyclase ADCY10 (sAC)
(Buck et al., 1999). The increase in cAMP stimulates protein kinase
A (PKA), which activates a series of pathways and coincides with
increased protein tyrosine phosphorylation (Harrison, 2004). Since
our first reports in 1995 (Visconti et al., 1995a,b), the increase in
tyrosine phosphorylation has been used as an endpoint of
capacitation in sperm from many species (Baldi et al., 2002;
Ficarro et al., 2003; Ijiri et al., 2012; Jagan Mohanarao and Atreja,
2011; Roy and Atreja, 2008; Signorelli et al., 2012). However, the
identity of the protein tyrosine kinase(s) responsible for this
signaling event has remained elusive. A list of potential candidate
kinases has emerged based on pharmacological and immunological
evidence. Among these candidates, the most relevant were SRC
(Baker et al., 2006; Krapf et al., 2010; Varano et al., 2008), FYN
(Luo et al., 2012), ABL (Baker et al., 2009), and both members of
the focal adhesion kinase (FAK) family, FAK and proline-rich
tyrosine kinase 2 (PYK2; also known as PTK2B) (Battistone et al.,
2014; Gonzalez-Fernandez et al., 2013). All these enzymes were
shown to be present in sperm and, furthermore, the increase in
tyrosine phosphorylation was reduced or completely obliterated
when treated with inhibitors against their respective activities.
Pharmacological inhibitors can be excellent tools to intervene in
particular cellular processes with accurate temporal precision.
However, small molecule inhibitors often have off-target effects
that confound identification of candidate enzymes involved in
specific processes. Therefore, to identify conclusively the tyrosine
kinase(s) responsible for capacitation, genetic approaches are
preferred.
In the present work, we show that PF431396, a commercially
available inhibitor of FAK and PYK2 tyrosine kinases, but
not PF573228, which has higher specificity for FAK than for
PYK2, blocks the capacitation-associated increase in tyrosine
phosphorylation without affecting the upstream phosphorylation
of PKA substrates. Yet, sperm from Pyk2−/− mice display normal
capacitation-associated increases in tyrosine phosphorylation.
These observations argue against a role for either PYK2 or FAK
in this process, and suggest that PYK2 inhibitors are acting on a
different tyrosine kinase(s) during sperm capacitation. Among the
candidates, FER has been recently shown to be phosphorylated on
tyrosine residues during capacitation (Chung et al., 2014). Here,
we show that: (1) FER and its testis-specific splicing variant FERT
are present in mature murine sperm; (2) FER enzymatic activity can
be inhibited by PF431396 with an IC50 comparable to that for
PYK2; and (3) sperm from mice targeted with a kinase-inactivating
mutation in Fer (FerDR/DR) do not display capacitation-associated
increases in tyrosine phosphorylation. Interestingly, FerDR/DR mice
are fertile, but their sperm are deficient in their ability to fertilize
metaphase II-arrested eggs in vitro. Altogether, these experiments
conclusively demonstrate FER involvement in the regulation of
tyrosine phosphorylation during capacitation. In addition, they
strongly suggest that the increase in tyrosine phosphorylation
accompanying capacitation is not essential for animal fertility and
challenge the current paradigm of sperm capacitation.Received 17 February 2016; Accepted 12 May 2016
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RESULTS
Members of the FAK tyrosine kinase family are present in
murine sperm but do not participate in the capacitation-
associated increase in tyrosine phosphorylation
Our recent work using human sperm (Battistone et al., 2014) as well
as previous work from Hinrichs’ group in stallion sperm (Gonzalez-
Fernandez et al., 2013) suggested a role for FAK tyrosine kinase
family members in the increase of protein tyrosine phosphorylation
that accompanies sperm capacitation. These conclusions were based
on the use of anti-phosphopeptide antibodies that recognize active
forms of these enzymes and on the use of PF431396, a tyrosine
kinase inhibitor considered to be most active against members of the
FAK kinase subfamily. Similar to observations in horse (Gonzalez-
Fernandez et al., 2013) and human (Battistone et al., 2014) sperm,
the increase of tyrosine phosphorylation in murine sperm was
inhibited in a dose-dependent fashion by PF431396, with an EC50
of ∼1 µM (Fig. 1A, upper panel). However, unlike the SRC
inhibitors SU6656 and SKI606 (Baker et al., 2006), PF431396 did
not block phosphorylation of PKA substrates, suggesting that its
inhibitory effect is downstream of PKA activation (Fig. 1A, lower
panel). This hypothesis is consistent with results indicating that
PF431396 blocks tyrosine phosphorylation (Fig. 1B, upper panel)
without inhibiting phosphorylation of PKA substrates, even when
sperm are incubated in the presence of cAMP agonists (e.g.
dbcAMP and IBMX) (Fig. 1B, lower panel).
We have previously shown that members of the SRC kinase
family affect the increase in tyrosine phosphorylation indirectly
by downregulation of Ser/Thr phosphatases (Krapf et al., 2010).
Therefore, the effect of SRC family kinase inhibitors such as
SU6656 or SKI606 on tyrosine phosphorylation can be overcome
when sperm are co-incubated with Ser/Thr phosphatase inhibitors
such as okadaic acid (Krapf et al., 2010). Contrary to these findings,
inhibition of tyrosine phosphorylation by 10 µM PF431396 was not
rescued by okadaic acid, even at concentrations as high as 100 nM
(Fig. 1C).
Considering that PF431396 can block both members of the FAK
family, we investigated the presence of FAK and PYK2 in sperm
extracts by western blotting. Both anti-PYK2 (Fig. 2A) and anti-
FAK (Fig. 2B) recognized bands of the expected molecular weight
(MW) (∼120 kDa) in soluble sperm fractions. Although both
antibodies also recognized additional bands at lower MWs, whether
or not these bands are related to either PYK2 or FAK has not been
established. As PF431396 can block both FAK and PYK2 tyrosine
kinases in vitro (Fig. 2C, left panel) (Bhattacharya et al., 2012),
these results were not sufficient to distinguish which member of the
FAK family is involved in sperm tyrosine phosphorylation. To
distinguish between PYK2 and FAK, PF573228, a different FAK
family inhibitor more selective for FAK than for PYK2, was used
(Fig. 2C, right panel). When murine sperm were incubated with
PF573228, only a slight decrease in tyrosine phosphorylation was
observed in capacitated sperm (Fig. 2D).
The results described above were consistent with the hypothesis
that PYK2 was the tyrosine kinase involved in sperm capacitation.
However, because many kinase inhibitors are not completely
specific, subsequent experiments were carried out using Pyk2−/−
mice (Okigaki et al., 2003). When sperm from Pyk2−/− mice were
incubated under capacitating conditions, the increase of protein
tyrosine phosphorylation was indistinguishable from that
corresponding to wild-type (WT) controls (Fig. 3A). In addition,
in WT and Pyk2−/− sperm, PF431396 (Fig. 3B) but not PF573228
(Fig. 3C) blocked the capacitation-associated increases of tyrosine
phosphorylation. These observations, together with results of
western blots using anti-PYK2 and anti-FAK antibodies (Fig. 3D),
implied that the normal increase in tyrosine phosphorylation was not
due to FAK compensation of the Pyk2−/− sperm phenotype. Finally,
Pyk2−/− mice were fertile (as previously described) (Okigaki et al.,
Fig. 1. PF431396 inhibits the capacitation-associated increase in
tyrosine phosphorylation. Sperm suspensions (106) were diluted in media
supplemented (CAP) or not (NON) with NaHCO3 and BSA and in the
presence of different compounds as detailed. After 1 h, sperm were analyzed
for protein phosphorylation with anti-phosphotyrosine (anti-PY) and anti-
phospho PKA substrates (anti-pPKAs). For each experiment (n=3), western
blots were analyzed using ImageJ. For comparison between blots, pixels for
each lane contained in the region marked by # (proteins in the 70-100 kDa
range for PY and 80-200 kDa for pPKAs) were quantified and normalized
using the CAP lane as reference (100%). The comparison between groups
was performed using two-tailed analysis of variance (ANOVA) in one-way
blocks. Multiple comparisons were performed by Tukey’s test. Bar graphs
represent mean±s.e.m. of the normalized values (**P<0.01). (A) PF431396
concentration curve. Sperm were incubated either in NON or CAP media with
increasing concentrations of PF431396, which was added from the beginning
of the 60 min incubation. Anti-PY and anti-pPKAs western blot analyses (left
panels) and ImageJ quantification (right panels) were conducted. (B)
PF431396 blocks cAMP-induced tyrosine phosphorylation. Sperm were
incubated either in NON or CAP media in the presence or absence of 1 mM
dbcAMP and 100 µM IBMX for 1 h in the presence or in the absence of 10 µM
PF431396. Quantification was conducted as described. (C) Okadaic acid
(OA) does not overcome inhibition by PF431396. Sperm were incubated for
1 h either in NON or in CAP media in the absence or in the presence of 10 µM
PF431396 and in the presence of increasing concentrations of OA. Analyses
were carried out as described.
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2003) and in vitro fertilization success rate was indistinguishable
from WT (Fig. 3E).
FER and FERT are responsible for the capacitation-
associated increase in tyrosine phosphorylation
The aforementioned results suggest that a PF431396-sensitive
tyrosine kinase distinct from FAK and PYK2 is present in mouse
sperm and is activated in response to in vitro capacitation. Recently,
Chung et al. (2014) conducted tyrosine phosphoproteomic analyses
in capacitated mouse sperm. A tyrosine phosphopeptide
corresponding to the FER activation-loop autophosphorylation
site was among the unique phosphopeptides identified. In addition
to the ubiquitously expressed FER, it is known that testicular germ
cells express a testis-specific splicing variant known as FERT
(Fischman et al., 1990; Kierszenbaum et al., 2008). Consistently,
antibodies against FER detected one band in murine spermatozoa at
∼50 kDa, corresponding to the predicted MW of FERT (Fig. 4A).
However, in some experiments, a second protein with a MW of
∼100 kDa (the predicted MW of somatic FER) was also observed
(e.g. Fig. 4F). Moreover, recombinant FER was sensitive to
PF431396 in vitro with an IC50 of ∼1 µM (Fig. 4B) suggesting
that this tyrosine kinase could be the PF431396 target in sperm.
Considering that most of the substrates phosphorylated on tyrosine
found in capacitated sperm are insoluble in non-ionic detergents
such as Triton X-100 (Fig. 4C), the solubility of FERT, PYK2 and
FAK was analyzed. Whereas PYK2 (Fig. 4D) and FAK (Fig. 4E)
were mostly present in the Triton X-100-soluble fractions, FERT
(Fig. 4F) was found in both the soluble and insoluble fractions.
Interestingly, most of the soluble FERT exhibited an increased
apparent MW, suggesting that FERT is post-translationally
modified during solubilization.
To explore further the involvement of FER in sperm tyrosine
phosphorylation pathways, we employed mice targeted with a
kinase-inactivating (D743R) mutation in Fer (Craig et al., 2001)
(FerDR/DR). Sperm from FerDR/DR mice did not display increased
tyrosine phosphorylation when incubated under conditions that
support capacitation (Fig. 5B, upper panel). Additionally,
phosphorylation of PKA substrates was not affected (Fig. 5B,
lower panel). FerDR/DR mice are fertile in vivo (Craig et al., 2001);
however, sperm from these mice almost completely failed to
fertilize metaphase II eggs in vitro (Fig. 5C). Other sperm
parameters, such as morphology, spontaneous and ionophore-
induced acrosome reaction, percentage of motile cells and
hyperactivation, were similar in WT, Pyk2−/− and FerDR/DR sperm
(Fig. S1).
The localization of proteins phosphorylated on tyrosine residues
has been accurately measured in three dimensions (3D) using
stochastic optical reconstruction microscopy (STORM), a super-
resolution imaging technique (Chung et al., 2014). STORM
measurements indicated that in the principal piece, tyrosine
phosphorylation is confined to the axoneme of the sperm
flagellum. Here, we used 3D STORM to evaluate the spatial
distribution of FER within the sperm flagellum. FER was found
throughout both the midpiece and principal piece (Fig. 6A). Cross-
sections of the images indicated that in the midpiece, FER localized
within 250 nm from the center (Fig. 6B). In the principal piece,
FER had a spatial distribution restricted to the axoneme (Fig. 6C).
A similar spatial distribution was observed for tyrosine
phosphorylation in both sections of the flagellum (Fig. 6D-F).
The coincident radius in the radial distributions of both signals
shows that FER localization overlaps with the localization of
tyrosine phosphorylation in both compartments of the sperm
flagellum (Fig. 6G,H). Consistent with immunofluorescence data
for FER and phosphotyrosine (Fig. S2A,B), no signal was detected
during the analysis of sperm heads by STORM. Probably owing to
instability of the FERDR/DR protein, FER (and FERT) is lost from
sperm from FerDR/DR mice (Fig. S2B,C).
DISCUSSION
During maturation in the epididymis, sperm acquire progressive
motility; however, they cannot fertilize until they reside in the
female tract for a period of time. The independent discovery of
capacitation by Chang (1951) and Austin (1951) set the stage for
development of in vitro fertilization techniques. Capacitation can be
mimicked in vitro in defined media (Buffone et al., 2014). At the
molecular level, capacitation is associated with sequential activation
of different signaling pathways including: (1) fast activation of
Fig. 2. Presence of FAK subfamily members in sperm and analysis of
in vitro activity. (A,B) Recombinant proteins (recPYK2, recFAK) or lysates
from sperm or Jurkat cells were subjected to western blotting with antibodies
for PYK2 (A) or FAK (B). (C) In vitro kinase activity of recombinant PYK2 and
FAK. Recombinant PYK2 and FAK (60 ng/reaction) were assayed using poly
Glu:Tyr as substrate as described. Each of the kinases (tested in triplicate) was
assayed in the presence of increasing concentrations of PF431396 (left) and
PF573228 (right). Numbers on the x-axis are expressed as logarithm of molar
concentration. Error bars are in the order of 0.002-0.01 and do not appear in the
graph. (D) PF573228 concentration curve. Sperm were incubated for 1 h in
NON or in CAP media with increasing concentrations of PF573228. Western
blotting using anti-PY antibodies (left) and ImageJ quantification (right) were
conducted from independent experiments (n=3). Bars represent the mean±
s.e.m. [**P<0.01 versus both CAP (0 μM PF573228) and NON CAP] of the
normalized values.
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cAMP synthesis (Visconti, 2009); (2) increase in intracellular pH
(pHi) (Parrish et al., 1989; Zeng et al., 1996); (3) hyperpolarization
of the plasma membrane (Escoffier et al., 2012; Zeng et al., 1995);
(4) increase in intracellular Ca2+ (Baldi et al., 1991; Carlson et al.,
2007; Marin-Briggiler et al., 2003); and (5) increase in tyrosine
phosphorylation (Visconti et al., 1995a). Our group has shown that
the increase in tyrosine phosphorylation is downstream of the
activation of a cAMP-dependent pathway (Visconti et al., 1995a,b).
However, the identity of the tyrosine kinase responsible for this
activation has remained elusive over the years.
In two subsequent papers, Baker and colleagues (Baker et al.,
2006; Mitchell et al., 2008) proposed SRC as the tyrosine kinase
responsible for the increase in tyrosine phosphorylation observed
during capacitation. These authors detected activation of SRC by
mass spectrometry during capacitation, and also showed that
inhibitors of SRC were able to block the capacitation-associated
increase in tyrosine phosphorylation. More recently, our group has
confirmed these observations (Krapf et al., 2010). However, we
showed that SRC inhibitors were capable of blocking the early
phosphorylation of PKA substrates as well. This inhibition of
phosphorylation pathways was overcome by co-incubation with
either okadaic acid or calyculin A, two very specific inhibitors of
Ser/Thr phosphatases (Krapf et al., 2010). Moreover, although
sperm from Src−/− mice were infertile and unable to fertilize
oocytes in vitro, they displayed normal increases in tyrosine
phosphorylation. Altogether, these results suggested that although
SRC and/or SRC kinase family members have essential roles
in the regulation of sperm function, SRC was not the tyrosine
kinase involved in the regulation of the increase in tyrosine
phosphorylation associated with capacitation.
Fig. 3. Sperm from Pyk2−/−mice undergo normal tyrosine
phosphorylation. (A) Tyrosine phosphorylation analysis.
Sperm from either wild-type (Pyk2+/+) or knockout (Pyk2−/−)
mice were incubated either under NON or CAP conditions.
After 1 h incubation, tyrosine phosphorylation was assessed
by anti-PY western blotting. Images are representative of three
independent experiments (n=3) using three different animals.
(B,C) PF431396 and PF573228 concentration curves. The
effect of PF431396 (B) and of PF573228 (C) on tyrosine
phosphorylation was analyzed as described for Fig. 1A.
(D) Anti-PYK2 and anti-FAK western blot analyses of Pyk2+/+
and Pyk2−/− sperm. Cauda epididymal sperm from either
Pyk2+/+ or Pyk2−/−mice were obtained in TYH-HEPES media
as described above, and sperm cell lysates prepared. The
presence of PYK2 and FAK was analyzed by independent
western blotting run in parallel. (E) Sperm from Pyk2−/−
animals are fertile in vitro. Cauda epididymal sperm from either
Pyk2+/+ or Pyk2−/− mice were collected in TYH media as
described in Materials and Methods and capacitated for 1 h,
and rates of in vitro fertilization (IVF) evaluated as described in
Materials and Methods. Bar graphs represent the mean±
s.e.m. of the normalized values of three independent
experimental replicates (n=3), using three different animals.
IVF data were analyzed by the simple χ2 test.
Fig. 4. Presence of FER in mouse sperm. (A) Presence of
FERT in mouse sperm. Sperm (or NIH3T3 cell lysates for
control) were analyzed by western blotting using anti-FER
antibodies. (B) FER in vitro kinase assay. Recombinant FER
(60 ng) in vitro kinase activity was assayed as described for
PYK2 and FAK in Fig. 2C. Values represent mean±s.e.m.
(n=3). Error bars are in the order of 0.01-0.08 and do not
appear in the graph. (C-F) Distribution of PYK2, FAK, FER and
PY substrates after solubilization with Triton X-100 (1%).
Cauda epididymal sperm obtained as described in Fig. 1 were
incubated in conditions that support capacitation for 1 h.
Sperm were then washed in PBS, and Triton X-100-treated
samples prepared as described in Materials and Methods.
Triton X-100-soluble (SOL) and insoluble (IN) fractions were
separated, boiled in SDS-sample buffer for 5 min and
analyzed bywestern blotting using anti-PY (C), anti -PYK2 (D),
anti -FAK (E) and anti -FER (F). Results are representative of
three independent experiments (n=3) using different animals.
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In 2013, Gonzalez-Fernandez et al. presented evidence
suggesting that kinases belonging to the FAK family were
responsible for the capacitation-associated increase of tyrosine
phosphorylation in stallion sperm (Gonzalez-Fernandez et al.,
2013). Similar to the case of SRC, this evidence was obtained using
antibodies recognizing active members of PYK2 and FAK, and
commercial inhibitors against this kinase family. Using a similar
approach, our group has recently proposed PYK2 as the kinase
responsible for tyrosine phosphorylation in human spermatozoa
(Battistone et al., 2014). Interestingly, contrary to SRC blockers,
results of this study showed that the FAK kinases inhibitor
PF431396 blocked tyrosine phosphorylation without inhibiting
phosphorylation of PKA substrates. Altogether, these findings
suggested a role for FAK family members in the capacitation-
induced increase in tyrosine phosphorylation. However, this
hypothesis was based on the use of kinase inhibitors, which
might have off-target effects. To avoid this problem, we have used
a combination of pharmacological and genetic approaches in this
study. Similar to observations in stallion and human sperm, the
FAK/PYK2 inhibitor PF431396 blocked the increase in tyrosine
phosphorylation without affecting PKA activation. The more
specific FAK inhibitor PF573228 was significantly less effective
at blocking tyrosine phosphorylation in mouse sperm, suggesting
that FAK was not involved in this signaling event. Although these
results supported PYK2 as the tyrosine kinase involved in
capacitation, sperm from Pyk2−/− mice were fertile and exhibited
normal capacitation-induced tyrosine phosphorylation. The
increase in tyrosine phosphorylation in these sperm was blocked
with PF431396, but not with PF573228, suggesting that the absence
of PYK2 was not compensated by increased levels of FAK. In
addition, these data indicated that another tyrosine kinase sensitive
to PF431396 was responsible for the capacitation-associated
increase of tyrosine phosphorylation in mouse sperm.
Recent tandemmass spectrometry data has shown that the protein
kinase FER is present in mature mouse sperm and undergoes
tyrosine phosphorylation in its kinase domain during capacitation
(Chung et al., 2014). FER is a non-receptor tyrosine kinase closely
related structurally to the proto-oncogene Fes (feline sarcoma
oncogene; also known as Fps, Fujinami poultry sarcoma) (Greer,
2002). These kinases have been implicated in the regulation of cell-
cell and cell-matrix interactions. In this work, we show that anti-
FER antibodies recognize two bands by western blot in sperm
extracts; this result is consistent with the presence of the two known
mRNA splicing variants of Fer in testicular germ cells, which are
translated into the ubiquitously expressed p94-FER and the shorter
testis-specific p51-FERT. Both isoforms contain functional kinase
domains. In addition to its presence in sperm, in vitro kinase activity
experiments using recombinant FER demonstrated that this tyrosine
Fig. 5. Sperm from FerDR/DR mice do not display capacitation-associated
increases in tyrosine phosphorylation. (A,B) Sperm from either wild-type
(+/+) (A) or FerDR/DR (DR/DR) mice (B) were obtained as described for Fig. 1
and incubated under NON or CAP conditions. Time-dependent response by
phosphorylation of PKA substrates and by tyrosine phosphorylation was
assessed using anti-PY (upper panels) and anti-pPKAs (lower panels) by
western blotting. Images shown are representative of at least three
independent experiments (n=3). (C) Sperm from FerDR/DR mice are subfertile
in vitro. Cauda epididymal sperm from either wild-type (+/+) or FerDR/DR
(DR/DR) mice were obtained in TYH media and capacitated for 1 h, and IVF
rates were evaluated as described in Materials and Methods. Bar graphs
represent the mean±s.e.m. of the normalized values (**P<0.01) (n=3). IVF
data were analyzed by the simple χ2 test.
Fig. 6. Localization of FER and tyrosine-phosphorylated
proteins inmouse sperm by STORM. (A) 3DSTORM images of
FER in xy projection. The color represents the relative distance
from the focal plane along the z-axis. (B) FER localization in the
midpiece (MP), yz projection. (C) FER localization in the principal
piece (PP), yz projection. (D) 3D STORM images of tyrosine
phosphorylation (pY) in xy projection. The color represents the
relative distance from the focal plane along the z-axis. (E)
Tyrosine-phosphorylated protein (PY) localization in the MP, yz
projection. (F) Tyrosine-phosphorylated protein (PY) localization
in the PP, yz projection. (G) Radial distribution of FER and PY in
the MP. (H) Radial distribution of FER and PY in the PP. Images
are representative of 15 cells from three different animals for PY
analysis and of nine cells from three different animals for FER
analysis.
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kinase is sensitive to PF431396. Moreover, the IC50 for in vitro
kinase inhibition and the EC50 for inhibition of tyrosine
phosphorylation in capacitated sperm were in the same
concentration range.
FER function has been explored in vivo using a mouse model in
which the endogenous Fer locus is targeted with a missense
mutation (Craig et al., 2001). In the resulting D743R mutant, FER
and FERT proteins lack kinase activity, and the protein is unstable.
FerDR/DRmice show several defects, which implicate FER in growth
factor signaling (Craig et al., 2001), hematopoiesis (Senis et al.,
2003), tumorigenesis (Sangrar et al., 2015), regulation of the
cytoskeleton (Sangrar et al., 2007; Xu et al., 2004) and
inflammatory cell functions (Craig and Greer, 2002; Khajah et al.,
2013; McCafferty et al., 2002). Here, we used this murine model to
evaluate the role of FER and FERT in the capacitation-associated
increase of tyrosine phosphorylation. Our results showed that in
sperm from FerDR/DR animals, the initial PKA activation was
not affected. However, the increase in tyrosine phosphorylation
was obliterated. Interestingly, hexokinase type I remained
phosphorylated in tyrosine residues (Kalab et al., 1994) indicating
that tyrosine phosphorylation of this enzyme is not dependent on
FER. Altogether, these results indicate that FERT (or FER) is
responsible for the increase in tyrosine phosphorylation observed in
murine sperm during capacitation. Consistently, 3D-STORM
microscopy using anti-phosphotyrosine and anti-FER antibodies
showed coincident spatial distributions in both mid- and principal
piece in capacitated sperm flagella.
In the last 20 years, tyrosine phosphorylation has been used as a
marker of capacitation in sperm from mouse and other species.
Capacitation is defined as all biochemical and physiological
processes that render the sperm able to fertilize (Yanagimachi,
1994). As FerDR/DR mice are viable and fertile (Craig et al., 2001),
our findings suggest that, at least in mouse sperm, the capacitation-
associated increase in tyrosine phosphorylation is not required for in
vivo fertilization. However, our in vitro results do not exclude the
possibility that during natural mating, interactions between sperm
and the female environment compensate for the lack of FER.
Despite these results, FerDR/DR sperm are less able to fertilize
in vitro. Interestingly, mice lacking cysteine-rich secretory protein 1
(CRISP1) exhibited a similar phenotype. CRISP1 is expressed by
the epididymal epithelium, secreted and incorporated into sperm
during epididymal maturation (Da Ros et al., 2015). Although these
mice are fertile in vivo, their capacitated sperm have significantly
lower levels of tyrosine phosphorylation in vitro (Da Ros et al.,
2008). Both Crisp1−/− and FerDR/DR sperm exhibit reduced in vitro
fertilization rates, suggesting that the functional role of tyrosine
phosphorylation in vivo can be bypassed by yet undiscovered
mechanisms. The finding that tyrosine phosphorylation plays a role
in in vitro fertilization, together with results showing that the
increase in tyrosine phosphorylation during capacitation is
conserved in a variety of mammalian species, suggests that this
signaling pathway could play a role in species in which sperm
competition is relevant. However, direct evaluation of this
hypothesis requires further investigation.
MATERIALS AND METHODS
Materials
Reagents were purchased from various sources. Sodium bicarbonate
(NaHCO3), bovine serum albumin (BSA, fatty acid free), dibutyryl cAMP
(Bt2cAMP), 3-isobutyl-1-methylxanthine (IBMX), adenosine triphosphate
(ATP), magnesium chloride (MgCl2), manganese chloride (MnCl2),
aprotinin, leupeptin, sodium orthovanadate (NaVO4), p-nitrophenyl
phosphate (NPP), β-glycero phosphate (βGP), β-mercaptoethanol,
poly (Glu:Tyr)(1:4) and PF431396 were obtained from Sigma-Aldrich.
SU6656 was purchased from Cayman Chemical (Ann Harbor, MI, USA),
okadaic acid was provided by LC Laboratories (Woburn, MA, USA).
PF573228 was obtained from Selleck Biochem (Houston, TX, USA).
HEPES was purchased from Roche and paraformaldehyde from Electron
Microscopy Science (Hatfield, PA, USA). Radiolabeled adenosine
triphosphate (γ32P-ATP) was purchased from Perkin Elmer. Rabbit
monoclonal anti-phospho-PKA substrates (clone 100G7E, lot #18, anti-
pPKAs) (Navarrete et al., 2015), mouse monoclonal anti-total PYK2 (clone
5E2, lot #1) (Tang et al., 2002), rabbit polyclonal anti-FAK (cat# 3285, ot
#9) (Battistone et al., 2014) and mouse monoclonal anti-FER (cat#4268, lot
#2) (Greer, 2002) were purchased from Cell Signaling Technology. Mouse
monoclonal anti-phospho tyrosine (anti-PY) antibody (clone 4G10, lot
#2658756) (Navarrete et al., 2015) was obtained from EMD Millipore.
Peroxidase/conjugated anti-mouse IgG were obtained from Jackson
ImmunoResearch and peroxidase-conjugated anti-rabbit IgG from GE
Healthcare. Alexa Fluor 647-conjugated anti-mouse secondary antibody
was purchased from Invitrogen (ThermoFisher Scientific). His-Tag
recombinant PYK2, FAK and FER were purchased from Invitrogen.
Sample preparation
Animals were euthanized in accordance with the Institutional Animal Care
and Use Committee (IACUC) guidelines of University of Massachusetts.
Cauda spermatozoa were collected from CD1 retired breeders (Charles
River Laboratories, Wilmington, MA, USA) from young adult C57 (7- to
8-week-old mice), Pyk2−/− (Shen et al., 2011), FerDR/DR (Craig et al.,
2001) mice and their respective wild-type controls. Each cauda epididymis
was placed in 500 µl of a modified Krebs-Ringer medium (TYH/HEPES)
(Kito and Ohta, 2008). This medium does not support mouse sperm
capacitation. After 10 min incubation at 37°C (swim-out), epididymis
tissue debris was removed, and the suspension adjusted to a final
concentration of 1-2×107 cells/ml. The sperm were then incubated at 37°C
for the times indicated in each experiment, in the absence (NON) or in the
presence (CAP) of 15 mM NaHCO3 and 5 mg/ml BSA. To test the effect
of inhibitors, sperm were incubated under the conditions described above
in the presence of increasing concentrations of inhibitors as indicated.
These compounds were assayed for 1 h and were added from the
beginning of the incubation period. For in vitro fertilization (IVF) assays,
sperm were first incubated in modified TYH medium (without HEPES)
containing 25 mM NaHCO3 and 5 mg/ml BSA. The medium was
previously equilibrated in a humidified atmosphere of 5% CO2 at 37°C
(Wertheimer et al., 2008).
SDS-PAGE and immunoblotting
Sperm were collected by centrifugation, washed in 1 ml of PBS, re-
suspended in Laemmli sample buffer (Laemmli, 1970), boiled (5 min) and
centrifuged at 12,100 g. Supernatants were then supplemented with 5%
β-mercaptoethanol and boiled (3 min). Protein extracts were analyzed by
SDS-PAGE and electro-transferred to PVDF (Bio-Rad). Immunoblotting
was conducted with the appropriate antibodies: anti-pPKAs (clone
100G7E); anti-PY (clone 4G10); anti-FAK; anti PYK2 (5D2) and anti-
FER (5E2). PVDF membranes were blocked with 5% fish gelatin (for
anti-phosphoantibodies) and 5% fat-free milk in TBS containing 0.1%
Tween 20 (T-TBS) (for all the others) and antibodies used at a final
concentration of 1:1000. Secondary antibodies were diluted in T-TBS
(1:10,000). Enhanced chemioluminescence ECL Plus Kit (GE Healthcare)
was used for detection. Tyrosine phosphorylated hexokinase served as a
loading control (Porambo et al., 2012; Visconti et al., 1995a). When
necessary, PVDF membranes were stripped at 65°C for 20 min in 2%
SDS, 0.74% β-mercaptoethanol, 62.5 mM Tris, pH 6.5, and then washed
six times for 5 min each in T-TBS prior to re-probing. Image analysis was
conducted using ImageJ (http://imagej.nih.gov/ij). Western blotting
regions of interest (ROIs) used for quantification are indicated by a
vertical bar on the left of the respective graph. In all cases, results were
normalized arbitrarily considering the CAP lane as the unit value. Images
shown are representative of experiments repeated three times (n=3) using
three different animals.
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Recombinant kinase assay
Sixty nanograms of each GST-tagged recombinant kinase (PYK2, FAK and
FER) were assayed in a buffer containing: 25 mMHEPES (pH 7.2), 10 mM
MgCl2, 10 mMMnCl2, 10 µM aprotinin, 10 µM leupeptin, 100 µMNaVO4,
5 mM nitrophenyl phosphate (NPP), and 40 mM β-glycero phosphate
(βGP), with 40 µM ATP and 100 µM poly(Glu:Tyr) (1:4) as substrate for
20 min in the presence of 1 µCi of γ32P-ATP. Reactions were stopped by
adding 60% trichloric acid (final concentration 30%), cooling on ice for
20 min and centrifuging for 3 min at 10,000 g. Thirty microliters (30 µl) of
the supernatant were transferred to phosphocellulose paper (Whatman P81,
Millipore; 2 cm×2 cm). Papers were immersed in 5 mM phosphoric acid
and washed seven times with the same solution. At the end of the washes,
spotted papers were rinsed with ethanol and air-dried. Counts (cpm)
incorporated were evaluated in vials with 2.5 ml of scintillation fluid in a
Beckman counter LS6500. Values represent average of three independent
experimental replicates (n=3).
Mouse eggs collection and IVF assays
Metaphase II-arrested eggs were collected from 6- to 8-week-old, super-
ovulated C57BL/6 female mice (Charles River Laboratories) at 12 h after
human chorionic gonadotropin intraperitoneal injection (Wertheimer et al.,
2008). The cumulus-oocyte complexes were placed into a well with 500 µl
of TYH (without HEPES) media previously equilibrated in an incubator
with 5% CO2 at 37°C. Fertilization wells containing 25-40 eggs were
inseminated with sperm (final concentration of 2.5×105 cells/ml) that had
been incubated for 1 h and 20 min in TYHmedium supporting capacitation.
After 4 h of insemination, eggs were washed, moved into fresh TYH media,
and evaluated 24 h post-insemination. Two-cell-stage embryos were
assigned as fertilized. Values represent average of three independent
experimental replicates (n=3), using three different animals.
Analysis of solubility
The solubility of tyrosine kinases (PYK2, FAK and FER) under
investigation in sperm was assessed using 1% Triton X-100 after
incubation in media that support capacitation. Briefly, after 1 h
incubation, sperm were centrifuged at 1500 rpm (150 g) for 5 min and re-
suspended in 1% Triton X-100/PBS buffer containing protease and
phosphatase inhibitors. Cell lysis proceeded by incubation on ice for
30 min. Samples were then spun down at 14,000 rpm (17,500 g) at 4°C for
2 min, and both supernatant (Triton X-100-soluble fraction) as well as the
remaining pellets (Triton X-100-insoluble fraction) were analyzed by
western blotting. Images are representative of experiments repeated three
times (n=3).
Genotyping of Pyk2−/− and FerDR/DR
Genotyping of Pyk2−/− was performed as previously described (Shen et al.,
2011) using the following primers: Pyk2 wild type forward, 5′-GGAGG-
TCTATGAAGGTGTCTACACGAAC-3′; Pyk2 mutant forward, 5′-GCC-
AGCTCATTCCTCCCACTCAT-3′; Pyk2 reverse, 5′-CCTGCTGGCAG-
CCTAACCACAT-3′. Genotyping of FerDR/DR was evaluated following the
protocol by Craig et al. (2001).
Immunofluorescence and super-resolution microscopy
After capacitation, sperm were centrifuged at 800 g for 5 min, the pellet was
fixed in 4% paraformaldehyde for 10 min at room temperature (RT) and
then centrifuged at 800 g for 5 min. The pellet was re-suspended in PBS and
50 µl of this suspension were placed onto polylysine-coated coverslips for
10 min. Bound cells were permeabilized with 0.5% Triton X-100 in PBS for
5 min and blocked with 3% BSA in PBS for 1 h (RT). Primary antibodies
were diluted in 1% BSA, and incubated with cells overnight at 4°C in a
humidified chamber. Anti-PY antibody (clone 4G10; final concentration
1:1000), and anti-FER (clone 5D2) at a dilution of 1:50 were used. After
primary antibody incubation, cells were washed with T-PBS (0.5% Tween-
20 in PBS) three times for 5 min each, and then stained with Alexa Fluor
647-conjugated anti-mouse secondary antibody diluted in PBS containing
1% BSA (1:1000 for pY and 1:500 for FER) at RT for 1 h. Cells were then
washed with T-PBS three times for 5 min each and for STORM analysis
incubated with 50 nm gold nanoparticles (Nanopartz, Loveland, CO, USA)
that were used as fiducial markers for drift correction (only for STORM).
After washing, cells were immediately mounted. Imaging buffer for both
standard immunofluorescence and STORMwas 50 mM Tris-HCl (pH 8.0),
10 mMNaCl, 10% glucose, 0.56 mg/ml glucose oxidase, 34 µg/ml catalase,
10% glucose and 1% β-mercaptoethanol.
STORM imaging
Image stacks were acquired using Andor IQ 2.3 software in a custom-built
microscope equipped with an Olympus PlanApo 100×/1.45 objective
(Weigel et al., 2011). Alexa Fluor 647 was excited with a 638 nm laser
(DL638-050, CrystaLaser, Reno, NV, USA) under continuous
illumination. Initially, the photo-switching rate was sufficient to provide
a substantial fluorophore density. However, as fluorophores photo-
bleached, a 405 nm laser was introduced to accelerate the photo-switching
rate. The intensity of the 405 nm laser was adjusted to control the density
of active fluorophores. A cylindrical lens with a focal length of 1 m was
placed in the detection path in order to achieve 3D resolution as
previously described (Huang et al., 2008). The images were acquired in a
back-illuminated electron-multiplied charge-coupled device (EMCCD)
camera (Andor iXon DU-888) operated at −85°C at a rate of 23 frames/s.
Fifty-thousand frames were collected to generate a super-resolution
image.
Super-resolution image reconstruction and analysis
Single-molecule localization, drift correction using gold fiducial markers
and reconstruction were performed with ThunderSTORM, an ImageJ
plugin (Ovesny et al., 2014). In order to find the molecular radial
distributions, we selected regions of interest of the flagellum that were
found to lie in a straight line, and the center of the flagellar cross-section
was calculated in MATLAB with a custom-written algorithm. The
coordinates of the localized molecules were then transformed into
cylindrical coordinates (Chung et al., 2014), from which the distribution
of radial localization was computed.
Motility and acrosome reaction assays
Motility parameters were analyzed in capacitated sperm from the
different transgenic models using Hamilton-Thorne CASA system
(Beverly, MA, USA) and CASAnova software as described (Goodson
et al., 2011). Spontaneous and A23187 (10 µM)-induced acrosome
reaction was measured as described (Wertheimer et al., 2008) in sperm
from WT, Pyk2−/− and FerDR/DR mice. Briefly, capacitated sperm were
incubated with Ca2+ ionophore A23187 or DMSO (control) for 30 min,
and then stained with PNA-Alexa 488 (Molecular Probes, L-21409). The
number of sperm with or without acrosome was counted under a
fluorescence microscope. Data are expressed as percentage of reacted
sperm.
Statistics
Statistical analyses were performed using the software Infostat 2011 (www.
infostat.com.ar). All data were verified to accomplish the parametric
assumptions: homogeneity of variances and normality. For western blotting
experiments, experiments were repeated at least three times and comparison
between groups was performed by analysis of variance (ANOVA) in blocks.
Data from each western analysis was considered as a block and all treatments
were applied to it. When the ANOVA tests were signiﬁcantly different
between groups (P<0.05), multiple comparisons were performed by
Tukey’s test. For the IVF experiments, data was analyzed by χ2 test. P-
values (P<0.001, P<0.01 or P<0.05) were considered to be signiﬁcant as
indicated in the figure legends.
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